2
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Advanced Epithelial Ovarian Cancer: No Difference in Survival Rate Between Exploratory Laparotomy and Inadequate Debulking Surgery as Treatment Approach before Chemotherapy

, , , , , , & show all
Pages 260-263 | Published online: 14 Jul 2016

References

  • Piver MS. Ovarian carcinoma - A decade of progress. Cancer 1980; 54: 2706–2715.
  • Fuks Z, Rizel S, Biran S. Chemotherapeutic and surgical indication of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian cancer. J Clin Oncol 1988; 6: 509–516.
  • Louie KG, Ozols RF, Myers CE, et al. Long term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma. J Clin Oncol 1986; 4: 1579–1585.
  • Hainsworth JD, Grosh WW, Burnett LS, et al. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration. Ann Intern Med 1988; 108; 165–170.
  • Ozols RF, Young RC. Chemotherapy in ovarian cancer. Semin Oncol 1984; 11: 751–763.
  • Dembo AJ, Bush RS. Choice of postoperative therapy based on prognosic factors. Int J Radiat Oncol Biol Phys 1982; 8: 893–897.
  • Schwartz PE, Smith JP. Second-look operation in ovarian cancer. Am J Obstet Gynecol 1980; 138: 1124–1130.
  • Griffiths CT. Surgical resection of bulky tumor in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975; 42: 101–104.
  • Wharton JT, Herson J. Surgery for common epithelial tumors of the ovary. Cancer 1981; 48: 582–589.
  • Wils J, Blijham G, Naus A, et al. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma. J Clin Oncol 1986; 4: 1068–1073.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.